Andy Hurd is an operating partner at Cressey and Company, previously serving as chief executive officer of Mede Analytics, bringing with him over 25 years of experience in health care IT, including product and market innovation, as well as strategic partnerships.
Andy was CEO of Epocrates (NASDAQ: EPOC), which was purchased by athenahealth (NASDAQ: ATHN). Prior to Epocrates, Andy served as chair and CEO of Carefx, which was acquired by Harris Corporation (NYSE: HRS) in 2011. During his six-year tenure at Carefx, the company achieved strong growth in revenue, income, and shareholder value. Before Carefx, Hurdheld senior management positions at WebMD, LLC (NASDAQ: WBMD) and QuadraMed Corporation.
Andy holds a bachelor’s degree in business administration from Northern Arizona University, and he is a member of the board of directors of Ability Networks and the Cleveland Clinic Innovations Advisory Board.